Stockholders’ Equity (Tables)
|
3 Months Ended |
May 31, 2026 |
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
| Schedule of Stock Option Activity |
Option
activity for the three months ended May 31, 2026 and the year ended February 28, 2026 was as follows:
Schedule of Stock Option Activity
| | |
Options | | |
Weighted Average Exercise Price ($) | | |
Weighted Average Remaining Contractual Life (Yrs.) | | |
Aggregate Intrinsic Value ($) | |
| | |
| | |
| | |
| | |
| |
| Options outstanding at February 28, 2025 | |
| 76,342 | | |
| 52.69 | | |
| 1.60 | | |
| - | |
| Granted | |
| 914,825 | | |
| 4.39 | | |
| 2.28 | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| (76,342 | ) | |
| 52.69 | | |
| - | | |
| - | |
| Options outstanding at February 28, 2026 | |
| 914,825 | | |
| 4.39 | | |
| 2.28 | | |
| - | |
| Granted | |
| 200,000 | | |
| 2.64 | | |
| 2.94 | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| - | | |
| - | | |
| - | | |
| - | |
| Options outstanding May 31, 2026 | |
| 1,114,825 | | |
| 4.08 | | |
| 2.19 | | |
| - | |
| Options expected to vest in the future as of May 31, 2026 | |
| 175,000 | | |
| 2.64 | | |
| 2.93 | | |
| - | |
| Options exercisable at May 31, 2026 | |
| 939,825 | | |
| 4.35 | | |
| 2.05 | | |
| - | |
| Options vested, exercisable, and options expected to vest at May 31, 2026 | |
| 1,114,825 | | |
| 4.08 | | |
| 2.19 | | |
| - | |
|
| Schedule of Warranty Activity |
Warrant
activity for the three months ended May 31, 2026 and the year ended February 28, 2026 was as follows:
Schedule of Warranty Activity
| | |
Warrants | | |
Weighted Average Exercise Price
($) | | |
Weighted
Average Remaining Contractual Life
(Yrs.) | |
| Warrants outstanding at February
28, 2025 | |
| 3,015,885 | | |
| 5.36 | | |
| 3.84 | |
| Granted | |
| 1,998,104 | | |
| 3.34 | | |
| 3.96 | |
| Exercised | |
| (237,429 | ) | |
| 3.02 | | |
| - | |
| Forfeited or cancelled | |
| (17,979 | ) | |
| 128.32 | | |
| - | |
| Warrants outstanding
at February 28, 2026 | |
| 4,758,581 | | |
| 4.15 | | |
| 3.48 | |
| Granted | |
| 198,430 | | |
| 2.84 | | |
| 4.31 | |
| Exercised | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| - | | |
| - | | |
| - | |
| Warrants outstanding
at May 31, 2026 | |
| 4,957,011 | | |
| 4.10 | | |
| 3.27 | |
|
| Warrant [Member] |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
The
fair value of warrants issued during the three months ended May 31, 2026 was estimated using the Black-Scholes model with the following
assumptions.
Assumptions:
Schedule of Share Based Payments Award Stock Options Valuation Assumptions
| | |
2026 | | |
2025 | |
| Dividend yield | |
| 0 | % | |
| 0 | % |
| Risk-free interest rate | |
| 3.54%-3.83 | % | |
| 3.9%-4.1 | % |
| Expected volatility | |
| 117.3%-119.4 | % | |
| 156.4%-160.5 | % |
| Expected life (in years) | |
| 1.5-2.5 | | |
| 3.32-5.0 | |
|
| Share-Based Payment Arrangement, Option [Member] |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
The
fair value of stock-based awards was estimated using the Black-Scholes model with the following weighted average assumptions for the
three months ended May 31, 2026 and May 31, 2025.
Schedule of Share Based Payments Award Stock Options Valuation Assumptions
| | |
2026 | | |
2025 | |
| Dividend yield | |
| 0 | % | |
| 0 | % |
| Risk-free interest rate | |
| 3.89 | % | |
| 3.83%-4.06 | % |
| Expected volatility | |
| 136.86 | % | |
| 122.5%-139.7 | % |
| Expected life (in years) | |
| 3.0 | | |
| 3.0-5.0 | |
|
| Stock Appreciation Rights [Member] |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
| Schedule of Stock Option Activity |
SARs
activity for the three months ended May 31, 2026 and the year ended February 28, 2026 was as follows:
Schedule of Stock Option Activity
| | |
SARs | | |
Weighted Average Exercise Price
($) | | |
Weighted Average Remaining Contractual Life
(Yrs.) | | |
Aggregate Intrinsic Value
($) | |
| | |
| | |
| | |
| | |
| |
| SARs outstanding at February
28, 2025 | |
| 40,223 | | |
| 44.80 | | |
| 1.99 | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| (3,907 | ) | |
| 52.60 | | |
| - | | |
| - | |
| SARs outstanding at
February 28, 2026 | |
| 36,316 | | |
| 43.96 | | |
| 1.17 | | |
| - | |
| Granted | |
| - | | |
| - | | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| - | | |
| - | | |
| - | | |
| - | |
| SARs outstanding
May 31, 2026 | |
| 36,316 | | |
| 43.96 | | |
| 0.91 | | |
| - | |
| SARs expected to vest in the future as of
May 31, 2026 | |
| - | | |
| - | | |
| - | | |
| - | |
| SARs exercisable at
May 31, 2026 | |
| 36,316 | | |
| 43.96 | | |
| 0.91 | | |
| - | |
| SARs vested, exercisable,
and SARs expected to vest at May 31, 2026 | |
| 36,316 | | |
| 43.96 | | |
| 0.91 | | |
| - | |
|